Pfizer (PFE) revenue

Revenue · fiscal 2025
$62.58B

Pfizer (PFE) reported revenue of $62.58B in fiscal 2025 (the year ended December 31, 2025). That is 1.6% lower than the $63.63B of fiscal 2024. Figures as of 18 Nov 2026, 06:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$62.58B
Change on fiscal 2024
−1.6%
Growth, 5 years
+8.5% a year
Growth, 10 years
+2.5% a year
Highest on record
$101.18Bfiscal 2022
Lowest on record
$40.83Bfiscal 2018
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pfizer revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 8.5% a year; over ten years the rate was 2.5% a year. Across the 19 fiscal years on record (2007–2025), the highest was $101.18B in fiscal 2022 and the lowest $40.83B in fiscal 2018.

History · 19 fiscal years

Revenue by fiscal year

Pfizer revenue, year by year

Pfizer (PFE) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$62.58B 1.6% down
2024$63.63B 6.8% up
2023$59.55B 41.1% down
2022$101.18B 37.4% up
2021$73.64B 76.8% up
2020$41.65B 1.8% up
2019$40.91B 0.2% up
2018$40.83B 22.3% down
2017$52.55B 0.5% down
2016$52.82B 8.1% up
2015$48.85B 1.5% down
2014$49.61B 3.8% down
2013$51.58B 5.6% down
2012$54.66B 10.4% down
2011$61.04B 6.3% down
2010$65.17B 32.3% up
2009$49.27B 2.0% up
2008$48.30B 0.3% down
2007$48.42B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Pfizer and comparable companies
CompanyRevenueFiscal year
Abbott Laboratories ABT$44.33B2025
Novo Nordisk NVODKK 309.06B2025
Pfizer PFE$62.58B2025
Danaher DHR$24.57B2025
Intuitive Surgical ISRG$10.06B2025
Vertex Pharmaceuticals VRTX$12.00B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PFE

Pfizer, figure by figure

Pfizer (PFE) overview: price, valuation and scorecardAll health care companies by market value

Pfizer revenue: questions and answers

What is Pfizer's revenue?

Pfizer (PFE) reported revenue of $62.58B in fiscal 2025 (the year ended December 31, 2025). That is 1.6% lower than the $63.63B of fiscal 2024.

What is the growth rate of Pfizer's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 8.5% a year; over ten years the rate was 2.5% a year.

What are the highest and lowest revenue figures on record for Pfizer?

Across the 19 fiscal years on record (2007–2025), the highest was $101.18B in fiscal 2022 and the lowest $40.83B in fiscal 2018.

How is Pfizer's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pfizer (PFE) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/PFE/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.